Chen et al. developed a prostate-specific membrane antigen (PSMA)-targeted combinatorial drug delivery strategy to co-deliver DTX and enzalutamide, thereby synergistically inducing apoptosis in PCa cells. This evidence concerns the gene FOLH1 and posterior cortical atrophy.